Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease.

Matsuda S, Kotani T, Ishida T, Fukui K, Fujiki Y, Suzuka T, Nagai K, Hata K, Shoda T, Isoda K, Ito Y, Makino S, Takeuchi T, Arawaka S.

Rheumatology (Oxford). 2019 Jul 18. pii: kez301. doi: 10.1093/rheumatology/kez301. [Epub ahead of print]

PMID:
31321420
2.

A retrospective study of the effect of fibrinogen levels during fresh frozen plasma transfusion in patients with traumatic brain injury.

Nakae R, Yokobori S, Takayama Y, Kanaya T, Fujiki Y, Igarashi Y, Suzuki G, Naoe Y, Fuse A, Yokota H.

Acta Neurochir (Wien). 2019 Jul 15. doi: 10.1007/s00701-019-04010-3. [Epub ahead of print]

PMID:
31309303
3.

Tyrosinase-catalyzed oxidation of resveratrol produces a highly reactive ortho-quinone: Implications for melanocyte toxicity.

Ito S, Fujiki Y, Matsui N, Ojika M, Wakamatsu K.

Pigment Cell Melanoma Res. 2019 Jul 2. doi: 10.1111/pcmr.12808. [Epub ahead of print]

PMID:
31264351
4.

Plasmalogen mediates integration of adherens junction.

Takahashi T, Honsho M, Abe Y, Fujiki Y.

J Biochem. 2019 Jun 24. pii: mvz049. doi: 10.1093/jb/mvz049. [Epub ahead of print]

PMID:
31236591
5.

Impaired plasmalogen synthesis dysregulates liver X receptor-dependent transcription in cerebellum.

Honsho M, Dorninger F, Abe Y, Setoyama D, Ohgi R, Uchiumi T, Kang D, Berger J, Fujiki Y.

J Biochem. 2019 May 28. pii: mvz043. doi: 10.1093/jb/mvz043. [Epub ahead of print]

PMID:
31135054
6.

Peroxisomes control mitochondrial dynamics and the mitochondrion-dependent apoptosis pathway.

Tanaka H, Okazaki T, Aoyama S, Yokota M, Koike M, Okada Y, Fujiki Y, Gotoh Y.

J Cell Sci. 2019 May 31;132(11). pii: jcs224766. doi: 10.1242/jcs.224766.

PMID:
31076512
7.

Serum Glucose and Potassium Ratio as Risk Factors for Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.

Matano F, Fujiki Y, Mizunari T, Koketsu K, Tamaki T, Murai Y, Yokota H, Morita A.

J Stroke Cerebrovasc Dis. 2019 Jul;28(7):1951-1957. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.041. Epub 2019 May 3.

PMID:
31060790
8.

Dynamics of the nucleoside diphosphate kinase protein DYNAMO2 correlates with the changes in the global GTP level during the cell cycle of Cyanidioschyzon merolae.

Imoto Y, Abe Y, Okumoto K, Ohnuma M, Kuroiwa H, Kuroiwa T, Fujiki Y.

Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(2):75-85. doi: 10.2183/pjab.95.007.

9.

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.

Koike Y, Fujiki Y, Higuchi M, Fukuchi R, Kuwatsuka S, Murota H.

JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb. No abstract available.

10.

Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Tokai N, Yoshida S, Kotani T, Yoshikawa A, Kimura Y, Fujiki Y, Matsumura Y, Takeuchi T, Makino S, Arawaka S.

PLoS One. 2019 Jan 30;14(1):e0211750. doi: 10.1371/journal.pone.0211750. eCollection 2019.

11.

Efficacy of Thyrotropin-Releasing Hormone Analog for Protracted Disturbance of Consciousness due to Aneurysmal Subarachnoid Hemorrhage.

Shibata A, Matano F, Fujiki Y, Mizunari T, Murai Y, Yokota H, Morita A.

J Stroke Cerebrovasc Dis. 2019 Apr;28(4):988-993. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.036. Epub 2019 Jan 17.

PMID:
30660483
12.

Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum.

Abe Y, Honsho M, Itoh R, Kawaguchi R, Fujitani M, Fujiwara K, Hirokane M, Matsuzaki T, Nakayama K, Ohgi R, Marutani T, Nakayama KI, Yamashita T, Fujiki Y.

Life Sci Alliance. 2018 Dec 3;1(6):e201800062. doi: 10.26508/lsa.201800062. eCollection 2018 Dec.

13.

A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder.

Tanaka AJ, Okumoto K, Tamura S, Abe Y, Hirsch Y, Deng L, Ekstein J, Chung WK, Fujiki Y.

Cold Spring Harb Mol Case Stud. 2019 Feb 1;5(1). pii: a003483. doi: 10.1101/mcs.a003483. Print 2019 Feb.

14.

Onsite GTP fuelling via DYNAMO1 drives division of mitochondria and peroxisomes.

Imoto Y, Abe Y, Honsho M, Okumoto K, Ohnuma M, Kuroiwa H, Kuroiwa T, Fujiki Y.

Nat Commun. 2018 Nov 6;9(1):4634. doi: 10.1038/s41467-018-07009-z.

15.

Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis.

Suzuka T, Kotani T, Takeuchi T, Fujiki Y, Hata K, Yoshida S, Shoda T, Makino S, Arawaka S.

Int J Rheum Dis. 2019 Feb;22(2):303-313. doi: 10.1111/1756-185X.13414. Epub 2018 Nov 5.

PMID:
30398034
16.

Cell Death or Survival Against Oxidative Stress.

Miyata N, Okumoto K, Fujiki Y.

Subcell Biochem. 2018;89:463-471. doi: 10.1007/978-981-13-2233-4_20. Review.

PMID:
30378036
17.

Identification of Peroxisomal Protein Complexes with PTS Receptors, Pex5 and Pex7, in Mammalian Cells.

Okumoto K, Miyata N, Fujiki Y.

Subcell Biochem. 2018;89:287-298. doi: 10.1007/978-981-13-2233-4_12.

PMID:
30378028
18.

The cytosolic peroxisome-targeting signal (PTS)-receptors, Pex7p and Pex5pL, are sufficient to transport PTS2 proteins to peroxisomes.

Mukai S, Matsuzaki T, Fujiki Y.

Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):441-449. doi: 10.1016/j.bbamcr.2018.10.006. Epub 2018 Oct 5.

PMID:
30296498
19.

A newly isolated Pex7-binding, atypical PTS2 protein P7BP2 is a novel dynein-type AAA+ protein.

Niwa H, Miyauchi-Nanri Y, Okumoto K, Mukai S, Noi K, Ogura T, Fujiki Y.

J Biochem. 2018 Dec 1;164(6):437-447. doi: 10.1093/jb/mvy073.

PMID:
30204880
20.

Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.

Goto-Yamaguchi L, Yamamoto-Ibusuki M, Yamamoto Y, Fujiki Y, Tomiguchi M, Sueta A, Takeshita T, Iwase H.

Breast Cancer Res Treat. 2018 Nov;172(2):353-362. doi: 10.1007/s10549-018-4933-5. Epub 2018 Aug 27.

PMID:
30151737
21.

Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Tokai N, Yoshida S, Kotani T, Yoshikawa A, Kimura Y, Fujiki Y, Matsumura Y, Takeuchi T, Makino S, Arawaka S.

PLoS One. 2018 Aug 23;13(8):e0202601. doi: 10.1371/journal.pone.0202601. eCollection 2018. Erratum in: PLoS One. 2019 Jan 30;14(1):e0211750.

22.

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.

Fujiki Y, Yamamoto Y, Sueta A, Yamamoto-Ibusuki M, Goto-Yamaguchi L, Tomiguchi M, Takeshita T, Iwase H.

Oncotarget. 2018 Jul 17;9(55):30513-30526. doi: 10.18632/oncotarget.25495. eCollection 2018 Jul 17.

23.

General formulation of long-range degree correlations in complex networks.

Fujiki Y, Takaguchi T, Yakubo K.

Phys Rev E. 2018 Jun;97(6-1):062308. doi: 10.1103/PhysRevE.97.062308.

24.

Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.

Ishida T, Yoshida S, Kimura Y, Fujiki Y, Kotani T, Takeuchi T, Makino S, Arawaka S.

Lupus. 2018 Sep;27(10):1636-1643. doi: 10.1177/0961203318784649. Epub 2018 Jun 28.

PMID:
29954283
25.

Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study.

Konma J, Kotani T, Shoda T, Suzuka T, Fujiki Y, Nagai K, Hata K, Yoshida S, Takeuchi T, Makino S, Arawaka S.

Mod Rheumatol. 2018 Nov;28(6):1009-1015. doi: 10.1080/14397595.2018.1441658. Epub 2018 Mar 2.

PMID:
29442534
26.

New splicing variants of mitochondrial Rho GTPase-1 (Miro1) transport peroxisomes.

Okumoto K, Ono T, Toyama R, Shimomura A, Nagata A, Fujiki Y.

J Cell Biol. 2018 Feb 5;217(2):619-633. doi: 10.1083/jcb.201708122. Epub 2017 Dec 8.

27.

Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage.

Fujiki Y, Matano F, Mizunari T, Murai Y, Tateyama K, Koketsu K, Kubota A, Kobayashi S, Yokota H, Morita A.

J Neurosurg. 2018 Oct;129(4):870-875. doi: 10.3171/2017.5.JNS162799. Epub 2017 Nov 17.

PMID:
29148905
28.

Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.

Matsuda S, Yoshida S, Fujiki Y, Satomi H, Takeuchi T, Hirose Y, Makino S, Arawaka S.

Rheumatol Int. 2018 Apr;38(4):689-696. doi: 10.1007/s00296-017-3875-2. Epub 2017 Nov 10. Review.

PMID:
29127573
29.

Subarachnoid Aneurysmal Hemorrhage Associated with Coarctation of the Aorta: Case Report and Review of the Literature.

Nakae R, Fujiki Y, Yokobori S, Naoe Y, Yokota H.

J Nippon Med Sch. 2017;84(4):186-192. doi: 10.1272/jnms.84.186. Review.

30.

Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.

Hisanaga J, Kotani T, Fujiki Y, Yoshida S, Takeuchi T, Makino S.

Int J Rheum Dis. 2017 Dec;20(12):2182-2185. doi: 10.1111/1756-185X.13136. Epub 2017 Jul 27. No abstract available.

PMID:
28752606
31.

Plasmalogen homeostasis - regulation of plasmalogen biosynthesis and its physiological consequence in mammals.

Honsho M, Fujiki Y.

FEBS Lett. 2017 Sep;591(18):2720-2729. doi: 10.1002/1873-3468.12743. Epub 2017 Jul 28. Review.

32.

Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.

Yoshikawa A, Yoshida S, Kimura Y, Tokai N, Fujiki Y, Kotani T, Matsumura Y, Takeuchi T, Makino S.

Mod Rheumatol. 2018 Mar;28(2):227-234. doi: 10.1080/14397595.2017.1336865. Epub 2017 Jun 23.

PMID:
28644744
33.

BAK regulates catalase release from peroxisomes.

Fujiki Y, Miyata N, Mukai S, Okumoto K, Cheng EH.

Mol Cell Oncol. 2017 Mar 17;4(3):e1306610. doi: 10.1080/23723556.2017.1306610. eCollection 2017.

34.

Quantitative Comparison of the Intraoperative Utility of Indocyanine Green and Fluorescein Videoangiographies in Cerebrovascular Surgery.

Matano F, Mizunari T, Murai Y, Kubota A, Fujiki Y, Kobayashi S, Morita A.

Oper Neurosurg (Hagerstown). 2017 Jun 1;13(3):361-366. doi: 10.1093/ons/opw020.

PMID:
28521359
35.

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients.

Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, Takeuchi T, Makino S.

Mod Rheumatol. 2018 Jan;28(1):133-140. doi: 10.1080/14397595.2017.1318468. Epub 2017 May 11.

PMID:
28490218
36.

Generation of Peroxisome-Deficient Somatic Animal Cell Mutants.

Okumoto K, Fujiki Y.

Methods Mol Biol. 2017;1595:319-327. doi: 10.1007/978-1-4939-6937-1_29.

PMID:
28409474
37.

Experimental Systems to Study Yeast Pexophagy.

Yamashita SI, Oku M, Sakai Y, Fujiki Y.

Methods Mol Biol. 2017;1595:249-255. doi: 10.1007/978-1-4939-6937-1_24.

PMID:
28409469
38.

Assessing Pexophagy in Mammalian Cells.

Yamashita SI, Fujiki Y.

Methods Mol Biol. 2017;1595:243-248. doi: 10.1007/978-1-4939-6937-1_23.

PMID:
28409468
39.

Peroxisomal Membrane and Matrix Protein Import Using a Semi-Intact Mammalian Cell System.

Okumoto K, Honsho M, Liu Y, Fujiki Y.

Methods Mol Biol. 2017;1595:213-219. doi: 10.1007/978-1-4939-6937-1_20.

PMID:
28409465
40.

In Vitro PMP Import Analysis Using Cell-Free Synthesized PMP and Isolated Peroxisomes.

Liu Y, Honsho M, Fujiki Y.

Methods Mol Biol. 2017;1595:207-212. doi: 10.1007/978-1-4939-6937-1_19.

PMID:
28409464
41.

Blue Native PAGE: Applications to Study Peroxisome Biogenesis.

Okumoto K, Tamura S, Fujiki Y.

Methods Mol Biol. 2017;1595:197-205. doi: 10.1007/978-1-4939-6937-1_18.

PMID:
28409463
42.

Analysis of Plasmalogen Synthesis in Cultured Cells.

Honsho M, Fujiki Y.

Methods Mol Biol. 2017;1595:55-61. doi: 10.1007/978-1-4939-6937-1_6.

PMID:
28409451
43.

Peroxisome biogenesis: a novel inducible PEX19 splicing variant is involved in early stages of peroxisome proliferation.

Kinoshita N, Matsuura A, Fujiki Y.

J Biochem. 2017 Mar 1;161(3):297-308. doi: 10.1093/jb/mvw075.

PMID:
28391327
44.

Reduction of Ether-Type Glycerophospholipids, Plasmalogens, by NF-κB Signal Leading to Microglial Activation.

Hossain MS, Abe Y, Ali F, Youssef M, Honsho M, Fujiki Y, Katafuchi T.

J Neurosci. 2017 Apr 12;37(15):4074-4092. doi: 10.1523/JNEUROSCI.3941-15.2017. Epub 2017 Mar 14.

45.
46.

The VDAC2-BAK axis regulates peroxisomal membrane permeability.

Hosoi KI, Miyata N, Mukai S, Furuki S, Okumoto K, Cheng EH, Fujiki Y.

J Cell Biol. 2017 Mar 6;216(3):709-722. doi: 10.1083/jcb.201605002. Epub 2017 Feb 7.

47.

Localization of Protein Kinase NDR2 to Peroxisomes and Its Role in Ciliogenesis.

Abe S, Nagai T, Masukawa M, Okumoto K, Homma Y, Fujiki Y, Mizuno K.

J Biol Chem. 2017 Mar 10;292(10):4089-4098. doi: 10.1074/jbc.M117.775916. Epub 2017 Jan 25.

48.

Defining the dynamin-based ring organizing center on the peroxisome-dividing machinery isolated from Cyanidioschyzon merolae.

Imoto Y, Abe Y, Okumoto K, Honsho M, Kuroiwa H, Kuroiwa T, Fujiki Y.

J Cell Sci. 2017 Mar 1;130(5):853-867. doi: 10.1242/jcs.199182. Epub 2017 Jan 23.

49.

Retrograde suction decompression of a large internal carotid aneurysm using a balloon guide catheter combined with a blood-returning circuit and STA-MCA bypass: a technical note.

Matano F, Mizunari T, Kominami S, Suzuki M, Fujiki Y, Kubota A, Kobayashi S, Murai Y, Morita A.

Neurosurg Rev. 2017 Apr;40(2):351-355. doi: 10.1007/s10143-016-0808-6. Epub 2016 Dec 16.

PMID:
27987034
50.

Peroxisome biogenesis and human peroxisome-deficiency disorders.

Fujiki Y.

Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(10):463-477. Review.

Supplemental Content

Loading ...
Support Center